Amritpal Singh, Leukemia Fellow at MD Anderson Cancer Center, shared a post by Naveen Pemmaraju, Professor, Department of Leukemia, at UT MD Anderson Cancer Center adding:
“Thank you Dr. Pemmaraju for this insightful evening on BPDCN—grateful for your expert insights into this rare disease and its patient impact.”
Quotting Naveen Pemmaraju‘s post:
“Grateful to have the cherished annual opportunity to speak to our amazing Leukemia Fellows today on: BPDCN Updates for 2026 in the Leukemia Fellows’ Lecture Series hosted by Tapan Kadia & Guillermo Garcia-Manero MD.
It was wonderful to spend time and we had an engaging Q&A on BPDCN afterward!”
Other articles featuring Amritpal Singh on OncoDaily.